Article Text

Download PDFPDF
Recurrent juvenile granulosa cell tumor of the ovary managed by palliative radiotherapy
  1. M. Hirakawa,
  2. Y. Nagai,
  3. C. Yagi,
  4. T. Nashiro,
  5. M. Inamine and
  6. Y. Aoki
  1. Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
  1. Address correspondence and reprint requests to: Yoichi Aoki, MD, Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, 207 Uehara Nishihara, Okinawa 903-0215, Japan. Email: yoichi{at}med.u-ryukyu.ac.jp

Abstract

Prognosis in the few patients with advanced-stage juvenile granulosa cell tumor (JGCT) of the ovary has traditionally been unfavorable. We report a recurrent JGCT patient managed by palliative radiotherapy. A 37-year-old woman with recurrent JGCT received a combination of paclitaxel–carboplatin chemotherapy and then single-agent docetaxel, but her disease progressed with multiple abdominal masses and ascites. We chose palliative radiation therapy to relieve her complaints. Whole-abdominal external beam radiotherapy with pelvic boost was delivered. She tolerated the treatment well. After the completion of radiotherapy, ultrasonography showed shrinkage of the tumor, and the ascites disappeared. We should consider using radiation therapy in a palliative setting for such patients with recurrent JGCT suffering from abdominal complaints

  • carboplatin
  • juvenile granulosa cell tumor of the ovary
  • palliative radiotherapy
  • taxanes

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.